‘93/’94 Year-End Review and Outlook : Industry Outlook : Continuing low-grade growth in the national economy, coupled with hopes for stability--if not expansion--in California, is the backdrop for the year in business. Here is an assessment of key industries’ prospects.
This report was compiled by Times staff writer Donna K.H. Walters
PHARMACEUTICALS: The industry will muster forces against any health care reforms that would limit new drug prices. Meantime, a host of new genetically engineered drugs will enter the federal review pipeline. Blockbuster products could revive Wall Street’s interest.
